2-sulfamoylacetylphenol has been researched along with zonisamide in 5 studies
Studies (2-sulfamoylacetylphenol) | Trials (2-sulfamoylacetylphenol) | Recent Studies (post-2010) (2-sulfamoylacetylphenol) | Studies (zonisamide) | Trials (zonisamide) | Recent Studies (post-2010) (zonisamide) |
---|---|---|---|---|---|
6 | 0 | 0 | 922 | 121 | 382 |
Protein | Taxonomy | 2-sulfamoylacetylphenol (IC50) | zonisamide (IC50) |
---|---|---|---|
Carbonic anhydrase 12 | Homo sapiens (human) | 1.86 | |
Carbonic anhydrase 1 | Homo sapiens (human) | 1.86 | |
Carbonic anhydrase 2 | Homo sapiens (human) | 1.86 | |
Carbonic anhydrase 2 | Bos taurus (cattle) | 1.86 | |
Carbonic anhydrase 3 | Homo sapiens (human) | 1.86 | |
Carbonic anhydrase 4 | Homo sapiens (human) | 1.86 | |
Carbonic anhydrase 6 | Homo sapiens (human) | 1.86 | |
Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | 1.86 | |
Carbonic anhydrase 7 | Homo sapiens (human) | 1.86 | |
Carbonic anhydrase 9 | Homo sapiens (human) | 1.86 | |
Carbonic anhydrase 13 | Homo sapiens (human) | 1.86 | |
Carbonic anhydrase 14 | Homo sapiens (human) | 1.86 | |
Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | 1.86 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kanakubo, Y; Kitada, M; Komiya, M; Nakasa, H; Ohmori, S; Rikihisa, T | 1 |
Kitada, M; Kiuchi, M; Komiya, M; Nakasa, H; Ohmori, S; Rikihisa, T | 1 |
Kitada, M; Nakasa, H; Ohmori, S | 1 |
Kitamura, S; Kuwasako, M; Sugihara, K; Tatsumi, K | 1 |
Ariyoshi, N; Igarashi, T; Ishii, I; Kitada, M; Nakamura, H; Nakasa, H; Ohmori, S | 1 |
5 other study(ies) available for 2-sulfamoylacetylphenol and zonisamide
Article | Year |
---|---|
Formation of reductive metabolite, 2-sulfamoylacetylphenol, from zonisamide in rat liver microsomes.
Topics: Anaerobiosis; Animals; Anticonvulsants; Carbon Monoxide; Cytochrome P-450 Enzyme System; In Vitro Techniques; Isoxazoles; Male; Microsomes, Liver; NADP; Oxidation-Reduction; Phenols; Rats; Rats, Inbred Strains; Sulfonamides; Zonisamide | 1992 |
Characterization of human liver microsomal cytochrome P450 involved in the reductive metabolism of zonisamide.
Topics: Anticonvulsants; Cytochrome P-450 Enzyme System; Humans; In Vitro Techniques; Isoxazoles; Microsomes, Liver; Oxidation-Reduction; Phenols; Sulfonamides; Zonisamide | 1993 |
Formation of 2-sulphamoylacetylphenol from zonisamide under aerobic conditions in rat liver microsomes.
Topics: Aerobiosis; Animals; Anticonvulsants; Biotransformation; Isoxazoles; Kinetics; Male; Microsomes, Liver; Oxidation-Reduction; Oxygen; Phenols; Rats; Rats, Sprague-Dawley; Sulfonamides; Zonisamide | 1996 |
The role of mammalian intestinal bacteria in the reductive metabolism of zonisamide.
Topics: Aldehyde Oxidase; Aldehyde Oxidoreductases; Animals; Anti-Bacterial Agents; Anticonvulsants; Bacteria; Cecum; Cricetinae; Feces; Gastrointestinal Contents; Guinea Pigs; Intestinal Mucosa; Intestines; Isoxazoles; Male; Mesocricetus; Mice; Oxidation-Reduction; Phenols; Rabbits; Rats; Rats, Wistar; Species Specificity; Sulfonamides; Zonisamide | 1997 |
Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes.
Topics: Adult; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Epoxy Compounds; Erythromycin; Humans; Hydroxylation; In Vitro Techniques; Isoxazoles; Kinetics; Microsomes, Liver; Mixed Function Oxygenases; Nevirapine; Pharmaceutical Preparations; Phenols; Steroids; Sulfonamides; Triazolam; Zonisamide | 2002 |